7,7-Dimethyl-7,8-dihydro-1H-pyrano[4,3-b]pyridin-2(5H)-one, 1g

{[2-(benzyloxy)phenyl]methyl}(2-methylpropyl)amine, 95.0%, 2g

4,4'-Dichlorobenzhydrol>98.0%(GC)250g

5-Bromo-2-(isopropoxy)pyridine-4-boronic acid, 98%, 500mg

(3aS,4R,6S,6aR)-6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-amine, 98%, 100mg

tert-butyl [3,3'-biazetidine]-1-carboxylate hydrochloride, 95.0%, 250mg

2-Methoxy-5-formylphenylboronic acid, 98.0%, 1g

Tert-butyl (tetrahydro-2H-thiopyran-4-yl)carbamate, 98%, 5g

1-(4-Methyl-piperazin-1-ylmethyl)-propylamine, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-1701, L 60 m, Ø-Innen 0,25 mm, Filmd. 0,50 µm, 1 Stück

2-Chloro-7,8-dihydroquinolin-5(6H)-one, 95.0%, 1g

4-Chloro-1H-indole-7-carboxylic acid, 95.0%, 100mg

tert-Butyl 2-hydroxy-2-methylpropylcarbamate, 95.0%, 1g